Pro-gastrin releasing peptide (pro-GRP) in small cell lung cancer staging. Background: Serum pro-gastrin releasing peptide (pro-GRP) is known to be a specific biomarker in the diagnosis of small cell lung cancer (SCLC). Few data about its correlation with disease stage are available in real clinical life.